Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Roivant Sciences Ltd.

    NASDAQ: ROIV · Real-Time Price · USD
    11.62
    0.22 (1.93%)
    At close: Jun 26, 2025, 3:59 PM
    11.60
    -0.13%
    After-hours: Jun 26, 2025, 07:57 PM EDT

    Roivant Sciences Statistics

    Share Statistics

    Roivant Sciences has 679.81M shares outstanding. The number of shares has increased by -3.41% in one year.

    Shares Outstanding

    n/a
    		 679.81M

    Shares Change (YoY)

    n/a
    		 -3.41%

    Shares Change (QoQ)

    n/a
    		 -1.98%

    Owned by Institutions (%)

    n/a
    		 77.82%

    Shares Floating

    n/a
    		 418.04M

    Failed to Deliver (FTD) Shares

    n/a
    		 48

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 44.43M, so 6.54% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 44.43M

    Short % of Shares Out

    n/a
    		 6.54%

    Short % of Float

    n/a
    		 8.92%

    Short Ratio (days to cover)

    n/a
    		 9.68

    Valuation Ratios

    The PE ratio is -42.56 and the forward PE ratio is -9.6. Roivant Sciences's PEG ratio is 0.41.

    PE Ratio

    n/a
    		 -42.56

    Forward PE

    n/a
    		 -9.6

    PS Ratio

    n/a
    		 251.93

    Forward PS

    n/a
    		 3.3

    PB Ratio

    n/a
    		 1.56

    P/FCF Ratio

    n/a
    		 -8.67

    PEG Ratio

    n/a
    		 0.41
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Roivant Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 33.47, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 33.47

    Quick Ratio

    n/a
    		 33.47

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.09

    Debt / FCF

    n/a
    		 -0.12

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $31,996.7

    Profits Per Employee

    n/a
    		 $-189,406.39

    Employee Count

    n/a
    		 908

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 48.17M

    Effective Tax Rate

    n/a
    		 -7.07%

    Stock Price Statistics

    The stock price has increased by 9.93% in the last 52 weeks. The beta is 1.16, so Roivant Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.16

    52-Week Price Change

    n/a
    		 9.93%

    50-Day Moving Average

    n/a
    		 11.04

    200-Day Moving Average

    n/a
    		 11.23

    Relative Strength Index (RSI)

    n/a
    		 59.78

    Average Volume (20 Days)

    n/a
    		 6,443,187

    Income Statement

    In the last 12 months, Roivant Sciences had revenue of 29.05M and earned -171.98M in profits. Earnings per share was -0.24.

    Revenue

    n/a
    		 29.05M

    Gross Profit

    n/a
    		 28.14M

    Operating Income

    n/a
    		 -1B

    Net Income

    n/a
    		 -171.98M

    EBITDA

    n/a
    		 -1.1B

    EBIT

    n/a
    		 -1.11B

    Earnings Per Share (EPS)

    n/a
    		 -0.24
    Full Income Statement

    Balance Sheet

    The company has 2.72B in cash and 100.17M in debt, giving a net cash position of 2.62B.

    Cash & Cash Equivalents

    n/a
    		 2.72B

    Total Debt

    n/a
    		 100.17M

    Net Cash

    n/a
    		 2.62B

    Retained Earnings

    n/a
    		 116.06M

    Total Assets

    n/a
    		 5.44B

    Working Capital

    n/a
    		 4.85B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -839.45M and capital expenditures -4.6M, giving a free cash flow of -844.05M.

    Operating Cash Flow

    n/a
    		 -839.45M

    Capital Expenditures

    n/a
    		 -4.6M

    Free Cash Flow

    n/a
    		 -844.05M

    FCF Per Share

    n/a
    		 -1.16
    Full Cash Flow Statement

    Margins

    Gross margin is 96.86%, with operating and profit margins of -3453.32% and -591.96%.

    Gross Margin

    n/a
    		 96.86%

    Operating Margin

    n/a
    		 -3453.32%

    Pretax Margin

    n/a
    		 -2346.02%

    Profit Margin

    n/a
    		 -591.96%

    EBITDA Margin

    n/a
    		 -3784.84%

    EBIT Margin

    n/a
    		 -3453.32%

    FCF Margin

    n/a
    		 -2905.21%

    Dividends & Yields

    ROIV does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ROIV is $18, which is 54.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $18

    Price Target Difference

    n/a
    		 54.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 19.39

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist